List of publications

All the publications of the C3M teams.

Export in CSV
Erratum for Brahimi-Horn et al., “Local Mitochondrial-Endolysosomal Microfusion Cleaves the Voltage-Dependent Anion Channel 1 To Promote Survival in Hypoxia”.

Authors Brahimi-Horn MC, Lacas-Gervais S, Adaixo R, Ilc K, Rouleau M, Notte A, Dieu M, Michiels C, Voeltzel T, Maguer-Satta V, Pelletier J, Ilie M, Hofman P, Manoury B, Schmidt A, Hiller S, Pouysségur J, Mazure NM

Molecular and cellular biology Jan 2022

Childhood cancer survivorship care during the COVID-19 pandemic: an international report of practice implications and provider concerns.

Authors van den Oever SR, Pluijm SMF, Skinner R, Glaser A, Mulder RL, Armenian S, Bardi E, Berger C, Ehrhardt MJ, Gilleland Marchak J, Haeusler GM, Hartogh JD, Hjorth L, Kepak T, Kriviene I, Langer T, Maeda M, Márquez-Vega C, Michel G, Muraca M, Najib M, Nathan PC, Panasiuk A, Prasad M, Roganovic J, Uyttebroeck A, Winther JF, Zadravec Zaletel L, van Dalen EC, van der Pal HJH, Hudson MM, Kremer LCM,

Journal of cancer survivorship : research and practice Jan 2022

Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies.

Authors Krug A, Martinez-Turtos A, Verhoeyen E

Cancers Jan 2022

Deubiquitinase Inhibitors Impair Leukemic Cell Migration Through Cofilin Oxidation and Alteration of Actin Reorganization.

Authors Larbret F, Biber P, Dubois N, Ivanov S, Lafanechere L, Tartare-Deckert S, Deckert M

Frontiers in pharmacology Jan 2022

Identification of potentially anti-COVID-19 active drugs using the connectivity MAP.

Authors Bonnet R, Mariault L, Peyron JF

PloS one Jan 2022

SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis.

Authors Luci C, Vieira E, Bourinet M, Rousseau D, Bonnafous S, Patouraux S, Lefevre L, Larbret F, Prod'homme V, Iannelli A, Tran A, Anty R, Bailly-Maitre B, Deckert M, Gual P

Cellular and molecular gastroenterology and hepatology Jan 2022

AMPK-PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemia.

Authors Grenier A, Poulain L, Mondesir J, Jacquel A, Bosc C, Stuani L, Mouche S, Larrue C, Sahal A, Birsen R, Ghesquier V, Decroocq J, Mazed F, Lambert M, Andrianteranagna M, Viollet B, Auberger P, Lane AA, Sujobert P, Bouscary D, Sarry JE, Tamburini J

Cell reports Jan 2022

Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing.

Authors Knipping F, Newby GA, Eide CR, McElroy AN, Nielsen SC, Smith K, Fang Y, Cornu TI, Costa C, Gutierrez-Guerrero A, Bingea SP, Feser CJ, Steinbeck B, Hippen KL, Blazar BR, McCaffrey A, Mussolino C, Verhoeyen E, Tolar J, Liu DR, Osborn MJ

Molecular therapy : the journal of the American Society of Gene Therapy Jan 2022

MITF activity is regulated by a direct interaction with RAF proteins in melanoma cells.

Authors Estrada C, Mirabal-Ortega L, Méry L, Dingli F, Besse L, Messaoudi C, Loew D, Pouponnot C, Bertolotto C, Eychène A, Druillennec S

Communications biology Jan 2022

Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.

Authors Lamas NJ, Martel A, Nahon-Estève S, Goffinet S, Macocco A, Bertolotto C, Lassalle S, Hofman P

Cancers Dec 2021